Inflammation, mediated by the immune response to infection and sterile injury, is a major underlying cause of disease. Advances in understanding the molecular mechanisms of inflammation hold promise for developing future therapies for severe sepsis, shock, ischemia reperfusion injury, autoimmune diseases, and other debilitating diseases of national importance. Research supported by the NIGMS in the principle investigator's lab has revealed mechanisms to control inflammation by identifying and targeting specific cytokines, and by mapping and targeting specific neural circuits that control their activity. This work has now progressed to launching a new field, termed bioelectronic medicine, which holds promise as strategy to develop therapies using electronic devices to target anti-inflammatory neural circuits. The present proposal seeks to understand unanswered questions about the molecular mechanisms controlling inflammation as derived from three existing RO1 funded projects in the PI's laboratory. The first is to understand the identity and mechanisms of the reflex neural circuits that control immune responses. The second is to understand the biology of cytokine mediators of inflammation that are necessary and sufficient for disease causation. And the third is to understand the molecular mechanisms that regulate cytokine release under the influence of neurotransmitters, including regulation of cytokine gene expression and inflammasome activity. The successful completion of this work will provide significant new data necessary to develop therapeutic modalities for the prevention and treatment of inflammation using bioelectronic devices.
Work in principle investigator's lab launched the field of bioelectronic medicine, a new field that now holds promise as an alternative strategy to develop therapies. The idea is to target molecular mechanisms of inflammation with neuromodulating devices. The studies proposed here will provide significant data that can be used to modulate the neural circuitry to develop therapeutic modalities for the prevention and treatment of inflammatory diseases.
|Pavlov, Valentin A; Chavan, Sangeeta S; Tracey, Kevin J (2018) Molecular and Functional Neuroscience in Immunity. Annu Rev Immunol 36:783-812|
|Zanos, Theodoros P; Silverman, Harold A; Levy, Todd et al. (2018) Identification of cytokine-specific sensory neural signals by decoding murine vagus nerve activity. Proc Natl Acad Sci U S A 115:E4843-E4852|
|Caravaca, A S; Tsaava, T; Goldman, L et al. (2017) A novel flexible cuff-like microelectrode for dual purpose, acute and chronic electrical interfacing with the mouse cervical vagus nerve. J Neural Eng 14:066005|
|Olofsson, P S; Tracey, K J (2017) Bioelectronic medicine: technology targeting molecular mechanisms for therapy. J Intern Med 282:3-4|
|Zaghloul, Nahla; Addorisio, Meghan E; Silverman, Harold A et al. (2017) Forebrain Cholinergic Dysfunction and Systemic and Brain Inflammation in Murine Sepsis Survivors. Front Immunol 8:1673|
|Chavan, Sangeeta S; Pavlov, Valentin A; Tracey, Kevin J (2017) Mechanisms and Therapeutic Relevance of Neuro-immune Communication. Immunity 46:927-942|
|Okusa, Mark D; Rosin, Diane L; Tracey, Kevin J (2017) Targeting neural reflex circuits in immunity to treat kidney disease. Nat Rev Nephrol 13:669-680|
|Yang, H; Wang, H; Wang, Y et al. (2017) The haptoglobin beta subunit sequesters HMGB1 toxicity in sterile and infectious inflammation. J Intern Med 282:76-93|
|Chavan, Sangeeta S; Tracey, Kevin J (2017) Essential Neuroscience in Immunology. J Immunol 198:3389-3397|
|Olofsson, Peder S; Steinberg, Benjamin E; Sobbi, Roozbeh et al. (2016) Blood pressure regulation by CD4(+) lymphocytes expressing choline acetyltransferase. Nat Biotechnol 34:1066-1071|
Showing the most recent 10 out of 11 publications